3 results
Approved WMORecruiting
PRIMARY: Dose finding part (Phase 1):To assess the safety and tolerability of durvalumab when given in combination with lenalidomide and rituximab; ibrutinib; or bendamustine and rituximab to determine the recommended Phase 2 doses (RP2Ds) of each…
Post-market clinical follow-up of a magnetic bone conduction implant (Cochlear Baha® Attract System)
This post-market clinical follow-up investigation aims to evaluate the usability and the mid- to long-term performance of the Baha Attract System in terms of hearing outcomes and safety. The objective is to compare the hearing performance with the…
Approved WMOCompleted
To test the safety of using the Con-Cord table for stabilization of preterm infants according to the ABC approach.